Literature DB >> 320925

Defense mechanisms of the respiratory membrane.

G M Green, G J Jakab, R B Low, G S Davis.   

Abstract

The success or failure of pulmonary defense mechanisms largely determines the appearance of clinical lung disease. The lung is protected by interlucking systems of nonspecific and specific defenses. Inhaled substrances can be isolated by mechanical barriers or can be physically removed from the lung either by transport up the bronchial mucociliary escalator or by transport through interstitial and lymphatic channels leading to lymph nodes. Substances can be locally detoxified within the lung by interaction with secretory proteins, such as antibodies, or by neutralization and dissolution within phagocytic cells. The pulmonary alveolar macrophage is the central figure in the protection of the respiratory membrane, operating in all 3 of the nonspecific modes of defense and augmented by specific immunologic mechanisms as well. Alterations in macrophage function and physiology may be crucial in determining the effectiveness of pulmonary defense. Recent advances in the cell biology of the alveolar macrophage have led to a greater understanding of its complex funcition. The multiple origins of macrophages from local and circulating cell pools and the variability in their fate and lifespan reflect the multi-faceted role of this cell type. The importance of the interactions between macrophages, orther lung cells, and other defense mechanisms has become increasingly clear. As well as functioning as resident defender of the alveolus, the macrophage is an important effector of the pulmonary immune response and plays a key role in the pathogenesis of a wide variety of inflammatory, destructive, and fibrotic lung diseases. Humoral and cell-mediated immune responses amplify and direct lung defenses against infection and may also participate in protection against other agents. Immunoglobulin A and G, microbial neutralizing and opsonizing anti-bodies, and macrophage-stimulating T lymphocytes are the major immunospecific forms of lung defense. Infectious agents, cigarette smoke, air pollutants, industrial dusts, and a spectrum of coexistent disease states may impair pulmonary defense mechanisms and increase susceptibility to asute and chronic respiratory diseases. A thorough understanding of the ways in which the lung protects itself against the daily assault of infectious, toxic, and immunogenic materials should lead to a beter understanding of pathogenesis and consequences of lung disease and to better clinical care of the patient with respiratory disease.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 320925     DOI: 10.1164/arrd.1977.115.3.479

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN: 0003-0805


  81 in total

1.  The importance of lymphocytes in pulmonary health and disease.

Authors:  H Y Reynolds
Journal:  Lung       Date:  1978       Impact factor: 2.584

2.  Life in the allogeneic environment after lung transplantation.

Authors:  I Paradis; H Rabinowich; A Zeevi; S Yousem; B Noyes; R Hoffman; B Griffith; J Dauber
Journal:  Lung       Date:  1990       Impact factor: 2.584

3.  Comparative in vitro study of interactions between particles and respiratory surface macrophages, erythrocytes, and epithelial cells of the chicken and the rat.

Authors:  S G Kiama; J S Adekunle; J N Maina
Journal:  J Anat       Date:  2008-07-14       Impact factor: 2.610

4.  Lung cinescintigraphy in the dynamic assessment of ventilation and mucociliary clearance of asbestos cement workers.

Authors:  L Di Lorenzo; M Mele; M M Pegorari; A Fratello; C Zocchetti; D Capozzi
Journal:  Occup Environ Med       Date:  1996-09       Impact factor: 4.402

5.  Tracheal versus pulmonary deposition and clearance of inhaled Pasteurella haemolytica or Staphylococcus aureus in mice.

Authors:  L M Rodríguez; A López; M Merino-Moncada; J Martínez-Burnes; I Mondragón
Journal:  Can J Comp Med       Date:  1985-07

6.  Effect of zinc and phosphate on an antibacterial peptide isolated from lung lavage.

Authors:  F M LaForce; D S Boose
Journal:  Infect Immun       Date:  1984-09       Impact factor: 3.441

7.  Cell-surface glycoconjugate layer in the tubotympanic mucosa of the guinea pig as revealed by wheat germ agglutinin/gold labelling.

Authors:  F Tanimura; H Morioka; Y Murakami
Journal:  Eur Arch Otorhinolaryngol       Date:  1995       Impact factor: 2.503

8.  Cystic fibrosis ciliary dyskinesia substances and pulmonary disease. Effects of ciliary dyskinesia substances on neutrophil movement in vitro.

Authors:  G B Wilson; H H Fudenberg; M T Parise; E Floyd
Journal:  J Clin Invest       Date:  1981-07       Impact factor: 14.808

9.  Enhancement of bronchoalveolar cell recovery and stimulation of alveolar macrophage chemiluminescence and resistance to influenza virus after treatment with RU 41821 aerosol.

Authors:  A Rudent; F Michel; C Labarre; A M Quero; R Zalisz; P Smets
Journal:  Antimicrob Agents Chemother       Date:  1987-06       Impact factor: 5.191

10.  In vitro inhibition of murine macrophage migration by Bordetella pertussis lymphocytosis-promoting factor.

Authors:  B D Meade; P D Kind; J B Ewell; P P McGrath; C R Manclark
Journal:  Infect Immun       Date:  1984-09       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.